Evidence-informed writing on ED, hair loss, GLP-1 weight loss, and performance care — written clearly, without hype.
Start My Free Visit
No. 01
Abdomen, thigh, or back of the arm. Once a week. The part most people get wrong is everything around the needle.
No. 02
What a monthly price should include, how it compares to Wegovy, and the red flags the FDA says to watch for.
No. 03
Tirzepatide can weaken the pill for four weeks after each dose change. Semaglutide's label says it doesn't. What to do about it.
No. 04
Nothing is forbidden. But fried food, big plates, and sweet chai will tell you otherwise. Includes desi and Middle Eastern dishes.
No. 05
What changes, on what timeline, and which results are real versus the marketing-claim version.
No. 06
One is a pill, one is a liquid, and the trade-off is systemic exposure versus a twice-daily routine. Who each one fits.
No. 07
Oral has the evidence. Topical lowers systemic exposure. What each form trades off, and how to decide.
No. 08
Timing, food, alcohol, dose, vascular health — the right order to think through it before assuming the medication failed.
New writing from the Reading Room, sent the morning it's published. No spam, no upsells — just the journal.
By subscribing you agree to our privacy policy. Unsubscribe anytime.